Mckesson Corporation (MCK) will report its 2023 Q3 earnings on Wednesday, 01 February 2023, after market close. Wallstreet estimates an EPS of $6.36 and a revenue of $71.07 B in the upcoming results. Mckesson Corporation historically beated the wallstreet estimates 69% of the times.
About Mckesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The RxTS segment offers CoverMyMeds solution to help patients get the medications.